This is a StreetInsider.com Premium Only Page

(FRLN) – StreetInsider.com Reports

Feb 20, 2024 07:08 AM Acquisition of Freeline (FRLN) by Syncona Becomes Effective

Nov 28, 2023 06:08 AM H.C. Wainwright Downgrades Freeline (FRLN) to Neutral

Nov 22, 2023 07:30 AM Freeline (FRLN) Acquired by Syncona for $6.50/sh

Nov 22, 2023 07:25 AM Freeline Therapeutics Holdings (FRLN) Halted, News Pending

Oct 18, 2023 08:10 AM Wedbush Downgrades Freeline (FRLN) to Neutral

Oct 4, 2023 07:00 AM Freeline Therapeutics Holdings (FRLN) Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201

Aug 15, 2023 04:16 PM Freeline (FRLN) PT Raised to $4 at Stifel

May 31, 2023 04:14 PM Stifel Maintains Freeline (FRLN) at Hold (correction)

May 30, 2023 12:20 PM Freeline (FRLN) PT Raised to $5 at Wedbush

May 12, 2023 08:05 AM Freeline Therapeutics Holdings (FRLN) Announces ADS Ratio Change to 1:15

Apr 21, 2023 07:01 AM Freeline Therapeutics Holdings (FRLN) Announces Proposed ADS Ratio Change

Apr 5, 2023 06:44 AM Freeline (FRLN) PT Lowered to $2 at H.C. Wainwright

Apr 4, 2023 04:25 PM Stifel Downgrades Freeline (FRLN) to Hold

Apr 4, 2023 07:32 AM Freeline Therapeutics Holdings plc (FRLN) Reports FY 2022 Loss of $1.50

Apr 4, 2023 07:09 AM Freeline Therapeutics Holdings (FRLN) announces restructuring organization and pausing development of FLT190 to extend cash runway into Q2 2024

Nov 16, 2022 06:06 AM Freeline (FRLN) PT Lowered to $3 at BTIG

Aug 11, 2022 06:25 AM Freeline (FRLN) PT Lowered to $5 at BTIG

Jul 21, 2022 07:01 AM Freeline Therapeutics Holdings (FRLN) Reports Publication of Positive Long-Term Data on Freeline’s Gene Therapy Candidate FLT180a

Jul 11, 2022 11:17 AM Freeline (FRLN) PT Lowered to $3 at Wedbush

Jul 11, 2022 05:43 AM Freeline Therapeutics Holdings (FRLN) Reports Positive Data from B-LIEVE Dose-Confirmation Trial for FLT180a

Jun 3, 2022 04:01 PM Freeline Therapeutics Holdings (FRLN) Receives Nasdaq Notice Regarding Minimum Bid Price

Apr 19, 2022 08:01 AM Freeline Therapeutics Holdings (FRLN) Appoints Paul Schneider as Chief Financial Officer

Apr 4, 2022 08:20 AM Freeline (FRLN) PT Lowered to $10 at Stifel

Mar 24, 2022 09:35 AM Stifel Reiterates Buy Rating on Freeline (FRLN), Sees FLT190 Updates as Positive, but Needs More Clearance into True Therapeutic Benefit

Mar 24, 2022 07:06 AM Freeline Therapeutics Holdings (FRLN) Announces Updated Development Plan and Timelines for FLT190 for People with Fabry Disease

Mar 11, 2022 05:49 AM Freeline Therapeutics Holdings (FRLN) Prices $26.1M Direct ADS Offering at $1.05/ADS

Feb 11, 2022 03:50 PM Stifel Reiterates Buy Rating on Freeline (FRLN), Optimistic on FLT190 Despite Increasing Competition

Feb 3, 2022 07:10 AM Freeline Therapeutics Holdings (FRLN) Appoints Henning R. Stennicke as Chief Scientific Officer

Feb 1, 2022 03:21 AM Morgan Stanley Downgrades Freeline (FRLN) to Equalweight

Jan 7, 2022 06:13 AM Redburn Upgrades Freeline (FRLN) to Buy

Jan 6, 2022 07:03 AM Freeline Therapeutics Holdings (FRLN) Announces FDA Cleared IND Application for FLT201

Dec 17, 2021 03:39 PM Freeline (FRLN) PT Lowered to $12 at Stifel, Maintains 'Buy'

Dec 14, 2021 06:42 AM Freeline (FRLN) PT Lowered to $10 at Wedbush

Dec 13, 2021 05:43 PM Freeline Therapeutics Holdings (FRLN) Announces 2022 Corporate Priorities and Guidance

Nov 29, 2021 06:26 AM BTIG Starts Freeline (FRLN) at Buy

Nov 10, 2021 07:30 AM Kaleido Biosciences Inc. (KLDO) to Appoint Dr. Alison Long as Chief Medical Officer

Oct 19, 2021 08:25 AM Freeline (FRLN) PT Lowered to $9 at Morgan Stanley

Aug 18, 2021 07:15 AM Freeline (FRLN) PT Lowered to $20 at H.C. Wainwright

Aug 17, 2021 07:42 AM JPMorgan Downgrades Freeline (FRLN) to Neutral

Aug 17, 2021 06:43 AM Mizuho Securities Downgrades Freeline (FRLN) to Neutral

Aug 16, 2021 02:18 PM Freeline (FRLN) PT Lowered to $14 at Wedbush, Following Earnings

Aug 16, 2021 07:01 AM Freeline Therapeutics Holdings (FRLN) Appoints Michael J. Parini as CEO; Reports Earnings

Aug 13, 2021 06:33 AM Freeline Therapeutics Holdings (FRLN) announces Chief Medical Officer Julie Krop, MD will be leaving

Jun 30, 2021 04:13 PM Freeline Therapeutics Holdings (FRLN) Announces Appointment of Chief Technical Operations Officer James Bircher

May 19, 2021 06:08 AM H.C. Wainwright Starts Freeline (FRLN) at Buy

May 18, 2021 07:36 AM Freeline (FRLN) PT Lowered to $19 at Stifel

May 6, 2021 06:20 AM Guggenheim Starts Freeline (FRLN) at Buy

Apr 6, 2021 03:12 AM Freeline (FRLN) PT Lowered to $22 at Morgan Stanley

Mar 22, 2021 04:03 PM Mizuho Securities Starts Freeline (FRLN) at Buy

Mar 11, 2021 07:17 AM Freeline Therapeutics Holdings (FRLN) Appoints Colin Love, PhD to Board of Directors